ChromaDex

(NASDAQ:CDXC)

$1.70

Last update: 12:45PM (Delayed 15-Minutes)
Get Real Time Here

Day Range1.67 - 1.73	52 Wk Range1.15 - 4.03	Open / Close1.7 / -	Float / Outstanding66.4M / 74.5M
Vol / Avg.78.1K / 268.4K	Mkt Cap126.6M	P/E-	50d Avg. Price1.52
Div / Yield-	Payout Ratio-	Total Float66.4M	EPS-0.01

ChromaDex Stock (NASDAQ:CDXC), Quotes and News Summary

Q: What sector and industry does ChromaDex (CDXC) operate in?

ChromaDex is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

ChromaDex Stock (NASDAQ: CDXC) stock price, news, charts, stock research, profile.

Day Range1.67 - 1.73	52 Wk Range1.15 - 4.03	Open / Close1.7 / -	Float / Outstanding66.4M / 74.5M
Vol / Avg.78.1K / 268.4K	Mkt Cap126.6M	P/E-	50d Avg. Price1.52
Div / Yield-	Payout Ratio-	Total Float66.4M	EPS-0.01

Sector: Health Care.Industry: Life Sciences Tools & Services

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors.

Earnings

Q3 2022		Est.		Actual		Surprise
EPS		-0.060		-0.040		0.0200
REV		18.690M		17.063M		-1.627M

Q2 2022		Est.		Actual		Surprise
EPS		-0.080		-0.090		-0.0100
REV		18.650M		16.732M		-1.918M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

How do I buy ChromaDex (CDXC) stock?

You can purchase shares of ChromaDex (NASDAQ: CDXC) through any online brokerage.

View our list of the best stock brokerages.

Who are ChromaDex's (CDXC) competitors?

Other companies in ChromaDex’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codex DNA (NASDAQ:DNAY), Codexis (NASDAQ:CDXS), Personalis (NASDAQ:PSNL) and IsoPlexis (NASDAQ:ISO).

What is the target price for ChromaDex (CDXC) stock?

The latest price target for ChromaDex (NASDAQ: CDXC) was reported by HC Wainwright & Co. on Monday, August 29, 2022. The analyst firm set a price target for 5.50 expecting CDXC to rise to within 12 months (a possible 223.53% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for ChromaDex (CDXC)?

The stock price for ChromaDex (NASDAQ: CDXC) is $1.7 last updated Today at November 28, 2022, 5:45 PM UTC.

Does ChromaDex (CDXC) pay a dividend?

There are no upcoming dividends for ChromaDex.

When is ChromaDex (NASDAQ:CDXC) reporting earnings?

ChromaDex’s Q3 earnings are confirmed for Wednesday, November 2, 2022.

Is ChromaDex (CDXC) going to split?

There is no upcoming split for ChromaDex.

What sector and industry does ChromaDex (CDXC) operate in?

ChromaDex is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

SPY

QQQ

BTC/USD

DIA

GLD

TLT

SPY

QQQ